Pfizer (PFE) FY2022 results: revenue $101.2 billion, up 24.5% on the year
Pfizer Inc. (PFE) reported revenue of $101.2 billion for fiscal 2022, the year ended 31 December 2022, up 24.5% on the year before. Net income was $31.4 billion, up 42.7%, and diluted earnings per share $5.47. The figures are the company's own, from the 10-K it filed with the SEC on 23 February 2023.
Revenue
$101.2 billion
+24.5% on the year
FY2015FY2022
Operating margin
n/a
FY2015FY2022
Net income
$31.4 billion
+42.7% on the year
FY2015FY2022
Diluted EPS
$5.47
+42.1% on the year
FY2015FY2022
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Operating cash flow
29,267
32,580
14,403
-10.2%
Capital expenditure
3,236
2,711
2,226
+19.4%
Free cash flow
26,031
29,869
12,177
-12.8%
Free cash flow margin
25.7%
36.7%
29.2%
Cash from investing
-15,783
-22,546
-4,271
Cash from financing
-14,834
-9,816
-9,649
Depreciation and amortisation
5,064
5,191
4,681
-2.4%
Share-based compensation
872
1,182
756
-26.2%
Buybacks
2,000
0.0
0.0
Dividends paid
8,983
8,729
8,440
+2.9%
Dividend per share
$1.61
$1.57
$1.53
+2.5%
Diluted shares, weighted
5,733m
5,708m
5,632m
+0.4%
Balance sheet
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Shareholders' equity
95,661
77,201
63,238
+23.9%
Non-controlling interest
256
262
235
-2.3%
Debt
35,829
38,436
39,836
-6.8%
Operating lease liabilities
2,597
2,510
1,108
+3.5%
Other liabilities
62,862
63,067
49,812
-0.3%
Total liabilities and equity
197,205
181,476
154,229
+8.7%
Fixed assets
16,274
14,882
13,745
+9.4%
Goodwill
51,375
49,208
49,577
+4.4%
Intangible assets
43,370
25,146
28,337
+72.5%
Investments
33,812
43,540
30,699
-22.3%
Cash and equivalents
416
1,944
1,784
-78.6%
Receivables
10,952
11,479
7,913
-4.6%
Inventory
8,981
9,059
8,020
-0.9%
Other assets
32,025
26,218
14,154
+22.1%
Total assets
197,205
181,476
154,229
+8.7%
10-K for the year ended 31 December 2022, filed 23 February 2023: the filing.